# Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-i-first-in-human-dose-escalation-study-of-the-oral-sf3b1-modulator-h3b/

## Facts

| Field | Value |
| --- | --- |
| Author Names | David P. Steensma,Martin Wermke,Virginia M. Klimek,Peter L. Greenberg,Patricia Font,Rami S. Komrokji,Jay Yang,Andrew M. Brunner,Hetty E. Carraway,Lionel Adès,Aref Al‐Kali,Juan Manuel Alonso‐Domínguez,Ana Alfonso Piérola,Catherine C. Coombs,H. Joachim Deeg,Ian W. Flinn,James M. Foran,Guillermo Garcia‐Manero,Michael B. Maris,Malgorzata McMasters,Jean‐Baptiste Micol,Jaime Pérez de Oteyza,Felicitas Thol,Eunice S. Wang,Justin M. Watts,Justin Taylor,Richard M. Stone,Vikram Gourineni,Alyssa J. Marino,Huilan Yao,Benoit Destenaves,Xiaobin Yuan,Kun Yu,Sara Dar,Lernik Ohanjanian,Keisuke Kuida,Jianjun Xiao,Catherine Scholz,Antonio Gualberto,Uwe Platzbecker |
| Citations | 184 |
| DOI | 10.1038/s41375-021-01328-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41375-021-01328-9.pdf |
| OpenAlex ID | https://openalex.org/W3173409038 |
| PMID | 34172893 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Martin Wermke](https://scholariq.org/researchers/martin-wermke/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
